High-Throughput Luminescence-Based Serum Bactericidal Assay Optimization and Characterization to Assess Human Sera Functionality Against Multiple Shigella flexneri Serotypes
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011123 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Valentina Caradonna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Shigella flexneri, Serogroup. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Shigellosis represents a significant global health concern particularly affecting children under 5 years in low- and middle-income countries (LMICs) and is associated with stunting and antimicrobial resistance. There is a critical need for an effective vaccine offering broad protection against the different Shigella serotypes. A correlate of protection has not yet been established but there is a general consensus about the relevant role of anti-O-Antigen-specific IgG and its functionality evaluated by the Serum Bactericidal Assay (SBA). This study aims to characterize a high-throughput luminescence-based SBA (L-SBA) against seven widespread Shigella serotypes. The assay was previously developed and characterized for S. sonnei and S. flexneri 1b, 2a, and 3a and has now been refined and extended to an additional five serotypes (S. flexneri 4a, 5b, 6, X, and Y). The characterization of the assay with human sera confirmed the repeatability, intermediate precision, and linearity of the assays; both homologous and heterologous specificity were verified as well; finally, limit of detection and quantification were established for all assays. Moreover, different sources of baby rabbit complement showed to have no impact on L-SBA output. The results obtained confirm the possibility of extending the L-SBA to multiple Shigella serotypes, thus enabling analysis of the functional response induced by natural exposure to Shigella in epidemiological studies and the ability of candidate vaccines to elicit cross-functional antibodies able to kill a broad panel of prevalent Shigella serotypes in a complement-mediated fashion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
- GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy.
ORCID-Profile: Valentina Caradonna, Renzo Alfini, Carlo Giannelli, Omar Rossi, Francesca Mancini
Zitieren
APA
Caradonna, V., Pinto, M., Alfini, R., Giannelli, C., Iturriza, M., Micoli, F., Rossi, O., & Mancini, F. (2024). High-Throughput Luminescence-Based Serum Bactericidal Assay Optimization and Characterization to Assess Human Sera Functionality Against Multiple Shigella flexneri Serotypes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011123
Vancouver
Caradonna V, Pinto M, Alfini R, Giannelli C, Iturriza M, Micoli F, et al. High-Throughput Luminescence-Based Serum Bactericidal Assay Optimization and Characterization to Assess Human Sera Functionality Against Multiple Shigella flexneri Serotypes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011123
BibTeX
@article{Caradonna2024,
author = {Caradonna, Valentina and Pinto, Marika and Alfini, Renzo and Giannelli, Carlo and Iturriza, Miren and Micoli, Francesca and Rossi, Omar and Mancini, Francesca},
title = {High-Throughput Luminescence-Based Serum Bactericidal Assay Optimization and Characterization to Assess Human Sera Functionality Against Multiple Shigella flexneri Serotypes},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011123}
}
EUVIMED